If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,644.00    22.00 (0.84%)
Bid:
2,639.00
Ask:
2,641.00
Spread: 2.00 (0.076%)
Market Cap: £23.49b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Second Interim Dividend

Today 17:06

RNS Number : 0444L
Experian plc
03 July 2026
 

Experian plc

 

 

Second interim dividend - exchange rate and Irish dividend withholding tax

 

 

3 July 2026 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market that, further to the announcement on 20 May 2026 of a second interim dividend of 48.00 US cents per ordinary share payable on 24 July 2026 to shareholders on the register of members at the close of business on 26 June 2026, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 26 June 2026 to receive payment in US dollars, will be £1 = $1.33576. Accordingly, the sterling amount of dividend payable on 24 July 2026 to such shareholders will be approximately 35.9345 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 26 June 2026. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 118 4397

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and platforms. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland.

 

Learn more at experianplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQXLFBQDLBBBZ
Date   Source Headline
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan
30th Apr 20193:26 pmRNSTotal Voting Rights
10th Apr 20191:17 pmRNSAdditional Listing
4th Apr 20192:38 pmRNSIrrevocable and non-discretionary arrangement
29th Mar 20192:36 pmRNSTotal Voting Rights
25th Mar 20195:08 pmRNSTransaction in Own Shares
19th Mar 20194:22 pmRNSBlock listing Interim Review
14th Mar 20195:22 pmRNSTransaction in Own Shares
12th Mar 20195:33 pmRNSTransaction in Own Shares
28th Feb 20192:38 pmRNSTotal Voting Rights
27th Feb 20197:49 amRNSAmended: Update on proposed ClearScore acquisition
27th Feb 20197:00 amRNSUpdate on proposed ClearScore acquisition
20th Feb 201911:19 amRNSAdditional Listing
25th Jan 201911:00 amRNSIssue of Notes
23rd Jan 20199:15 amRNSAdditional Listing
17th Jan 20197:00 amRNSTrading update, third quarter
11th Jan 20195:52 pmRNSFirst interim dividend
3rd Jan 20194:56 pmRNSTransaction in Own Shares
2nd Jan 201911:02 amRNSShare repurchase programme - Correction
31st Dec 201812:45 pmRNSShare repurchase programme
31st Dec 201811:48 amRNSTotal Voting Rights
21st Dec 20185:02 pmRNSTransaction in Own Shares
20th Dec 20185:03 pmRNSTransaction in Own Shares
19th Dec 20185:04 pmRNSTransaction in Own Shares
14th Dec 20182:49 pmRNSDirectorate Change
13th Dec 20184:53 pmRNSElections for first interim dividend
11th Dec 201812:04 pmRNSExperian signs new Revolving Credit Facility
10th Dec 20181:30 pmRNSExperian agrees to acquire Compuscan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.